Class III
Terminated
Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
Why: Defective Container: Customer complaints of punctures in the bottle.
- Company
- Orexigen Therapeutics, Inc.
La Jolla, CA, United States - Reported
- Aug 22, 2018
- Recall started
- Aug 9, 2018
- Ended
- Nov 15, 2019
- Where sold
- Nationwide in the USA
- Amount
- 95,296 bottles
- Full product description
- Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
- Lots / codes affected
- Lot #: ZCXM, Exp 01NOV2020; ZCXN, Exp 02NOV2020; ZCXP, Exp 09NOV2020; ZCXS, 10NOV2020; ZCXT, Exp 13NOV2020; and ZCXV, Exp 17NOV2020
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.